News Releases

Date	Title
Aug 12, 2021	Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights
Aug 05, 2021	Homology Medicines Appoints Gene Therapy Pioneer Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board
Aug 04, 2021	Homology Medicines to Participate in Upcoming Investor Conferences
May 13, 2021	Homology Medicines Announces Presentations on its Expanding Genetic Medicines Platform and Internal GMP Manufacturing at the American Society of Gene & Cell Therapy Annual Meeting
May 06, 2021	Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
May 03, 2021	Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
Apr 28, 2021	Homology Medicines Announces New Approach to Leverage AAVHSC Platform by Delivering One-Time In Vivo Gene Therapy to Produce Antibodies in Humanized Murine Model
Apr 14, 2021	Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting
Apr 12, 2021	Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer
Apr 07, 2021	Homology Medicines Announces Pricing of Public Offering of Common Stock